INS and metabolic dysfunction-associated steatotic liver disease: NAFLD is not only characterized by lipotoxicity resulting from imbalanced de novo lipogenesis (DNL) but also by an impaired rate of lipid disposal, coupled with systemic insulin resistance (2).